Frailty-stratified randomised controlled bayesian adaptive trial of bortezomib versus lenalidomide in transplant-ineligible myeloma - the FRAIL-M study (MRFF LSCD Grant Administered by Monash) (2019–2023)

Grant type:
Monash University
Researchers:
  • Head, PA-Southside Clinic
    Princess Alexandra Hospital Southside Clinical Unit
    Faculty of Medicine
    Affiliate Professor
    Centre for Health Services Research
    Faculty of Medicine
Funded by:
Monash University